"bioskin is a full-service Contract Research Organisation - CRO - specialized in dermatology which provides strategic and regulatory consulting, IND and NDA development for dermatology and related products, early phase human safety and Proof-of-Concept studies, vasoconstrictor assays according to FDA guideline, and global Phase II-IV trials for NCEs, new formulations with known actives and generics"

During the past decade, Bioskin GmbH conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bioskin GmbH" #1 sponsor was "Pfizer" with 4 trials, followed by "LEO Pharma" with 2 trials sponsored, "BSN Medical GmbH" with 1 trials sponsored, "Boston Pharmaceuticals" with 1 trials sponsored and "Circassia Limited" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bioskin GmbH" #1 collaborator was "Bioskin GmbH" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Bioskin GmbH" are "Psoriasis" (4 trials), "Atopic Dermatitis" (2 trials), "Psoriasis Vulgaris" (2 trials), "Androgenic Alopecia" (1 trials) and "Chronic Plaque Psoriasis" (1 trials). Many other conditions were trialed in "Bioskin GmbH" in a lesser frequency.

Most popular intervention types in "Bioskin GmbH" are "Drug" (12 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Vehicle" (3 trials), "Betnesol®-V Creme, 0.1%" (2 trials), "Placebo" (2 trials), "0.005% calcipotriol" (1 trials) and "0.1% betamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bioskin GmbH" are 8 trials for "All" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Bioskin GmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Bioskin GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bioskin GmbH, 11 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".